InsiderClue
Stocks · Health care · Services-Misc Health & Allied Services, NEC

Fresenius Medical Care AG

FMS Clue Score45
Germany CIK 0001333141
$21.06 +0.86% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $21.06 −39.83% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue17.78Operating income2.36Net income1.28EPS, diluted4.16Fiscal year 2018Revenue16.55 −7.0%Operating income3.04Net income1.98 +54.9%EPS, diluted6.45 +55.0%Fiscal year 2019Revenue17.48 +5.6%Operating income2.27Net income1.20 −39.5%EPS, diluted3.96 −38.6%Fiscal year 2020Revenue17.86 +2.2%Operating income2.30Net income1.16 −2.9%EPS, diluted3.96 +0.0%Fiscal year 2021Revenue17.62 −1.3%Operating income1.85Net income0.97 −16.8%EPS, diluted3.31 −16.4%Fiscal year 2022Revenue19.40 +10.1%Operating income1.51Net income0.67 −30.5%EPS, diluted2.30 −30.5%Fiscal year 2023Revenue19.45 +0.3%Operating income1.37Net income0.50 −25.9%EPS, diluted1.70 −26.1%Fiscal year 2024Revenue19.34 −0.6%Operating income1.39Net income0.54 +7.8%EPS, diluted1.83 +7.6%Fiscal year 2025Revenue19.63 +1.5%Operating income1.83Net income0.98 +81.9%EPS, diluted3.36 +83.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 17.78 16.55 17.48 17.86 17.62 19.40 19.45 19.34 19.63
Growth −7.0% +5.6% +2.2% −1.3% +10.1% +0.3% −0.6% +1.5%
Operating income 2.36 3.04 2.27 2.30 1.85 1.51 1.37 1.39 1.83
Net income 1.28 1.98 1.20 1.16 0.97 0.67 0.50 0.54 0.98
Growth +54.9% −39.5% −2.9% −16.8% −30.5% −25.9% +7.8% +81.9%
EPS, diluted 4.16 6.45 3.96 3.96 3.31 2.30 1.70 1.83 3.36
Growth +55.0% −38.6% +0.0% −16.4% −30.5% −26.1% +7.6% +83.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin33.8%Operating margin13.3%Net margin7.2%Free cash flow margin7.0%Fiscal year 2018Gross margin31.2%Operating margin18.4%Net margin12.0%Free cash flow margin6.1%Fiscal year 2019Gross margin30.9%Operating margin13.0%Net margin6.9%Free cash flow margin8.3%Fiscal year 2020Gross margin31.0%Operating margin12.9%Net margin6.5%Fiscal year 2021Gross margin28.8%Operating margin10.5%Net margin5.5%Fiscal year 2022Gross margin27.4%Operating margin7.8%Net margin3.5%Fiscal year 2023Operating margin7.0%Net margin2.6%Fiscal year 2024Operating margin7.2%Net margin2.8%Fiscal year 2025Operating margin9.3%Net margin5.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 33.8% 31.2% 30.9% 31.0% 28.8% 27.4% n/a n/a n/a
Operating margin 13.3% 18.4% 13.0% 12.9% 10.5% 7.8% 7.0% 7.2% 9.3%
Net margin 7.2% 12.0% 6.9% 6.5% 5.5% 3.5% 2.6% 2.8% 5.0%
Free cash flow margin 7.0% 6.1% 8.3% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow2.19Capital expenditure−0.94Free cash flow1.25Buybacks−0.06Dividends paid−0.29Fiscal year 2018Operating cash flow2.06Capital expenditure−1.06Free cash flow1.00 −19.5%Buybacks−0.04Dividends paid−0.32Fiscal year 2019Operating cash flow2.57Capital expenditure−1.12Free cash flow1.44 +43.6%Buybacks−0.60Dividends paid−0.35Fiscal year 2020Operating cash flow4.23Buybacks−0.37Dividends paid−0.35Fiscal year 2021Operating cash flow2.49Fiscal year 2022Operating cash flow2.17Fiscal year 2023Operating cash flow2.63Fiscal year 2024Operating cash flow2.39Fiscal year 2025Operating cash flow2.68Buybacks−0.59
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 2.19 2.06 2.57 4.23 2.49 2.17 2.63 2.39 2.68
Capital expenditure −0.94 −1.06 −1.12 n/a n/a n/a n/a n/a n/a
Free cash flow 1.25 1.00 1.44 n/a n/a n/a n/a n/a n/a
Growth −19.5% +43.6%
Buybacks −0.06 −0.04 −0.60 −0.37 n/a n/a n/a n/a −0.59
Dividends paid −0.29 −0.32 −0.35 −0.35 n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.98Total debt6.68Net cash (debt)−5.70Shareholders’ equity9.82Debt to equity0.68Fiscal year 2018Cash2.15Total debt6.15Net cash (debt)−4.01Shareholders’ equity11.76Debt to equity0.52Fiscal year 2019Cash1.01Total debt7.91Net cash (debt)−6.90Shareholders’ equity11.96Debt to equity0.66Fiscal year 2020Cash1.08Total debt7.81Net cash (debt)−6.73Shareholders’ equity11.22Debt to equity0.70Fiscal year 2021Cash1.48Total debt7.31Net cash (debt)−5.83Shareholders’ equity12.70Debt to equity0.58Fiscal year 2022Cash1.27Total debt7.86Net cash (debt)−6.59Shareholders’ equity13.99Debt to equity0.56Fiscal year 2023Cash1.40Total debt7.45Net cash (debt)−6.04Shareholders’ equity13.62Debt to equity0.55Fiscal year 2024Cash1.18Total debt6.84Net cash (debt)−5.66Shareholders’ equity14.58Debt to equity0.47Fiscal year 2025Cash1.60Total debt7.29Net cash (debt)−5.69Shareholders’ equity13.31Debt to equity0.55
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.98 2.15 1.01 1.08 1.48 1.27 1.40 1.18 1.60
Total debt 6.68 6.15 7.91 7.81 7.31 7.86 7.45 6.84 7.29
Net cash (debt) −5.70 −4.01 −6.90 −6.73 −5.83 −6.59 −6.04 −5.66 −5.69
Shareholders’ equity 9.82 11.76 11.96 11.22 12.70 13.99 13.62 14.58 13.31
Debt to equity 0.68 0.52 0.66 0.70 0.58 0.56 0.55 0.47 0.55

In billions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
17.78 16.55 17.48 17.86 17.62 19.40 19.45 19.34 19.63
Growth −7.0% +5.6% +2.2% −1.3% +10.1% +0.3% −0.6% +1.5%
11.77 11.39 12.08 12.32 12.85 14.50 14.53 14.58 14.60
6.02 5.15 5.40 5.54 5.08 5.31 n/a n/a n/a
Growth −14.3% +4.7% +2.6% −8.3% +4.6%
0.11 0.11 0.17 0.19 0.22 0.23 0.23 0.18 0.16
3.64 2.89 3.03 3.13 2.77 3.17 3.20 3.14 3.03
2.36 3.04 2.27 2.30 1.85 1.51 1.37 1.39 1.83
Growth +28.6% −25.3% +1.5% −19.6% −18.4% −9.4% +1.7% +31.2%
2.00 2.74 1.84 1.94 1.57 1.22 1.03 1.06 1.51
0.44 0.51 0.40 0.50 0.35 0.32 0.30 0.32 0.32
1.28 1.98 1.20 1.16 0.97 0.67 0.50 0.54 0.98
Growth +54.9% −39.5% −2.9% −16.8% −30.5% −25.9% +7.8% +81.9%
Per share
4.17 6.47 3.96 3.96 3.31 2.30 1.70 1.83 3.36
4.16 6.45 3.96 3.96 3.31 2.30 1.70 1.83 3.36
Growth +55.0% −38.6% +0.0% −16.4% −30.5% −26.1% +7.6% +83.6%
306.6 306.5 302.7 294.1 292.9 293.2 293.4 293.4 291.2

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 1.9% a year over five years, and earnings per share fell 3.2% a year.
  • Operating margin is down 3.6 points on five years ago, at 9.3%.
  • Profitable in every one of the 9 years on file.